2005
DOI: 10.1002/mrc.1545
|View full text |Cite
|
Sign up to set email alerts
|

NMR spectroscopic analysis of new spiro‐piperidylrifamycins

Abstract: New spiro-piperidylrifamycin derivatives are presented. These compounds were synthesized from the reaction of 3-amino-4-iminorifamycin S and enantiomerically pure 4-piperidones, which generate diasteroisomeric rifabutin analogues with a new stereocentre at the spiranic carbon. The 1 H and 13 C NMR spectra of these new compounds, and also the configuration of the new stereogenic centres, were assigned using 2D NMR spectroscopic techniques. A preliminary study of the 1 H and 13 C NMR spectra of the starting comp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Many attempts at modification of the natural product rifamycin SV have been proposed and performed up to now, e.g. by introduction of alkylthio chain or alkylthio chain containing sugar moieties at C‐3 atom,7 removal of acetyl group at C‐25 atom from the ansa bridge,8 simultaneous introduction of amine group at C‐3 atom and imino group at C‐4 position or linkage of C‐3 and C‐4 positions by various substituted spiro9 or heterocyclic10 moieties. Because of some problems associated with the use of rifampicin in therapy against tuberculosis following from its toxicity,11 the interactions with the other drugs,12 resistance of some bacterial strains as well as taking into account important role of the substituent at C‐3 atom and the key role of hydroxyl groups for the presence of high antibacterial activity of Rif, we have synthesised series of its novel aza‐analogues (R1–R7—Scheme ).…”
Section: Methodsmentioning
confidence: 99%
“…Many attempts at modification of the natural product rifamycin SV have been proposed and performed up to now, e.g. by introduction of alkylthio chain or alkylthio chain containing sugar moieties at C‐3 atom,7 removal of acetyl group at C‐25 atom from the ansa bridge,8 simultaneous introduction of amine group at C‐3 atom and imino group at C‐4 position or linkage of C‐3 and C‐4 positions by various substituted spiro9 or heterocyclic10 moieties. Because of some problems associated with the use of rifampicin in therapy against tuberculosis following from its toxicity,11 the interactions with the other drugs,12 resistance of some bacterial strains as well as taking into account important role of the substituent at C‐3 atom and the key role of hydroxyl groups for the presence of high antibacterial activity of Rif, we have synthesised series of its novel aza‐analogues (R1–R7—Scheme ).…”
Section: Methodsmentioning
confidence: 99%
“…37,38 Furthermore, it was evidenced that for various rifamycins (including rifabutin, rifapentine, rifaximin, and rifampicin) the conformation of the ansa bridge and its arrangement relative to the central core are dependent on the phase (solid/liquid) or polarity and nature (protic/aprotic) of the solvent used. [39][40][41][42] The conformation exibility of the ansa chain for ansamycins, e.g. rifamycins, is not always concerned with atropisomerism, however, is crucial for chameleonic properties of this-type macrolactams, reected in a facile adaptation to the changing cell environment during Review Natural Product Reports transport of the drug to the target site.…”
Section: Structural Aspects Of Naphthalenoid Ansamycins Influencing T...mentioning
confidence: 99%
“…Both of these compounds have the same stereochemical configuration at the spiranic carbon C-1Ј, which was determined to be R by 2D nuclear magnetic resonance (NMR), nuclear Overhauser effect spectroscopy (gNOESY), and rotational Overhauser effect spectroscopy (ROESY) experiments ( Fig. 1) (12). In the present study, we report in greater detail the in vitro antimycobacterial properties of RFA-1 and RFA-2 against a wide panel of RIF-susceptible and multidrug-resistant strains of M. tuberculosis and study the basis for their enhanced bioactivity by molecular dynamics calculations.…”
mentioning
confidence: 99%